Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 284,818 shares at $16.98 ($4.8M) on 2019-12-12, disclosed to the SEC on 2019-12-13.
Open-market sale of $4.8M VNDA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.92 | 72,373 | $1.2M | 25.4% |
| 2 | $16.92 | 72,373 | $1.2M | 25.4% |
| 3 | $16.98 | 70,036 | $1.2M | 24.6% |
| 4 | $16.98 | 70,036 | $1.2M | 24.6% |
| Total | $16.95 avg | 284,818 | $4.8M | 100% |
| Filing → |
| VNDA | BUY | 2025-05-21 | $44K | — | Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |